Comparative study of efficacy and safety of topical 0.005% Calcipotriene and topical 0.1% Tazarotene in patients of Palmo-plantar psoriasis
Journal Title: International Journal of Medical and Health Research - Year 2019, Vol 5, Issue 1
Abstract
Background: Topical therapies are the first line of treatment for patients with palmoplanter psoriasis affecting both palms and soles. Although in use for more than a decade yet we could not find any reports of studies directly comparing calcipotriol and tazarotene. Aim: To evaluate the comparative efficacy and safety of calcipotriol and tazarotene in the treatment of palmoplanter psoriasis. Methods: This was an observational, open level, two groups comparative, longitudinal follow up(every 4week), 12-week study using calcipotriol 0.005% ointment applied twice daily (group A) versus0.1% ointment tazarotene (group B) applied once daily, each group having 40 patients. Efficacy was determined by the assessment of target psoriatic lesions under evaluation by using the severity scale (0-3) of erythema, scaling, fissuring and infiltration (ESIF score). Evaluation was done at baseline (0 week), 4 weeks, 8 weeks, and 12 weeks of treatment. At the end of 12 weeks reduction in the ESIF score was compared in patients of both groups. Safety of this study was evaluated by comparing the adverse drug reaction in each group. Results: Forty-one patients in group A (Calcipotriol group) completed the study. In this group reduction in ESI score was significant at 12 weeks in patients treated with topical calcipotriol, producing moderate-to-marked improvement (P< 0.0001). In group B (Tazarotene group), improvement was comparable in lesions treated with calcipotriol at the end of 12 weeks after the topical treatment by 0.1% tazarotene. Adverse effects noted were mild - in the form of burning, pruritus, and irritation - and were observed more often in the lesions treated with tazarotene as compared to those in the lesions treated with calcipotriol, but the difference was not statistically significant. However, none of the patients discontinued the therapy because of adverse events. Conclusion: In conclusion, topical 0.005% Calcipotriol and topical 0.1% Tazarotene both are efficacious in treatment of palmoplanter with almost same safety profile.
Authors and Affiliations
Dr. Ashok Kumar Keer, Dr. MP Shukla, Dr. Dileep Dandotiya
Keywords
Related Articles
- EP ID EP581778
- DOI -
- Views 135
- Downloads 0
Delayed generalized edema after marine sting in the Arabian Gulf: A case report
Introduction: Marine stings and envenomation is very common cause of visit to the emergency in the coastal cities. Here, we report a case of a marine sting that caused a delayed edematous reaction in a diabetic patient....
Organogenesis & histogenesis of kidney in human fetuses at different weeks of gestation
Kidneys develop in early in 5th week and start to function around 9th week in the intermediate mesoderm of human embryos as metanephric kidney. Kidney is covered by a thick capsule made up of fibrous tissue beneath which...
Correlation of zinc levels to oxidative status in idiopathic chronic pancreatitis
Background: Causative factor of chronic pancreatitis is unknown. Idiopathic Chronic pancreatitis is especially prevalent in India. Among multiple factors, Oxidative stress induced free radicals is one implicated factor i...
Prevalence of obesity and overweight amongst adolescents in rural and urban areas of Rajasthan India
Background: Overweight and obesity is a global problem affecting millions of adolescents in developed as well as developing world. This is not only associated with predisposition to chronic systemic illnesses like diabet...
Psychosocial and Health related issues among Elderly Population in a Rural Population of Barabanki, Uttar Pradesh
Background: Population ageing is recognised international reality in both developed and developing countries like India. The present cross-sectional study was undertaken to study psychosocial and health related issues am...